|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C12N 5/07 | |||
| C12N 5/16 | |||
| C12P 21/08 | |||
| C07K 16/28 | |||
| G01N 33/68 |
| (11) | Number of the document | 2569013 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11781385.7 |
| Date of filing the European patent application | 2011-05-13 | |
| (97) | Date of publication of the European application | 2013-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/036535 |
| Date | 2011-05-13 |
| (87) | Number | WO 2011/143624 |
| Date | 2011-11-17 |
| (30) | Number | Date | Country code |
| 395652 P | 2010-05-14 | US |
| (72) |
LIU, Jie, US
WEISSMAN, Irving L., US
MAJETI, Ravindra, US
|
| (73) |
The Board of Trustees of the Leland Stanford Junior University,
Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038,
US
|
| (54) | HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47 |
| HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47 |